Crossmark

Hepatic Arterioportal Fistula Is Associated with Decreased Future Liver Remnant Regeneration after Stage-I ALPPS for Hepatocellular Carcinoma

Crossref DOI link: https://doi.org/10.1007/s11605-021-05022-0

Published Print: 2021-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ye, Chunhui

Zhang, Ling

Xu, Banghao

Li, Jian

Lu, Tingting

Zeng, Jingjing

Guo, Ya

Peng, Minhao

Bao, Li

Wen, Zhang

Wang, Jilong https://orcid.org/0000-0002-6798-2227
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81560387, 81902983)

Natural Science Foundation of Guangxi Province (2018JJB140382)

“Medical Excellence Award” funded by the creative research development grant from the first affiliated hospital of Guangxi Medical University (180327)

Guangxi medical and health technology development and application project (S2019097, S2018100)

the project to improve the basic scientific research ability of young and middle-aged teachers of universities and colleges in Guangxi (2019KY0123)
License Information

Text and Data Mining valid from 2021-09-01
More Information

This article is maintained by: Elsevier

Article Title: Hepatic Arterioportal Fistula Is Associated with Decreased Future Liver Remnant Regeneration after Stage-I ALPPS for Hepatocellular Carcinoma

Journal Title: Journal of Gastrointestinal Surgery

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s11605-021-05022-0

Content Type: article

Copyright: Copyright © 2021 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.